Not applicableUnknownNCT05075928What this trial is testingDescription of a Cohort of Covid-19 Patients With a Circulating AnticoagulantWho this might be right forSARS-COV-2 University Hospital, Strasbourg, France 100
Not applicableNot Yet RecruitingNCT06884384What this trial is testingDOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort StudyWho this might be right forAntiphospholipid Syndrome (APS)Cohort StudyThrombotic and Bleeding Events Central Hospital, Nancy, France 310
Testing effectiveness (Phase 2)Study completedNCT06315530What this trial is testingEffect of Telitacicept on Antibody Titers in Primary APS PatientsWho this might be right forAntiphospholipid Syndrome (APS) Ruijin Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT07584083What this trial is testingAnifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)Who this might be right forAntiphospholipid Syndrome (APS) National and Kapodistrian University of Athens 20
Not applicableStudy completedNCT05313048What this trial is testingProspective Observational Study to Evaluate a Possible Change in APS Antibody Profiles After COVID-19 Infection or VaccinationWho this might be right forAntiphospholipid SyndromeCOVID-19 InfectionCOVID-19 Vaccination Cardioangiologisches Centrum Bethanien 82
Not applicableStudy completedNCT05195372What this trial is testingEffectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid SyndromeWho this might be right forAntiphospholipid SyndromeVenous ThromboembolismArterial Thromboembolism+1 more Cardioangiologisches Centrum Bethanien 80
Early research (Phase 1)WithdrawnNCT00278616What this trial is testingHematopoietic Stem Cell Transplantation in Patients With Antiphospholipid SyndromeWho this might be right forANTIPHOSPHOLIPID SYNDROME Richard Burt, MD
Testing effectiveness (Phase 2)Ended earlyNCT02128269What this trial is testingPhase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid SyndromeWho this might be right forAntiphospholipid (aPL)-Positive Alexion Pharmaceuticals, Inc. 9
Testing effectiveness (Phase 2)WithdrawnNCT00180778What this trial is testingSteroids and Antiphospholipid Syndrome- Related Pregnancy LossWho this might be right forAntiphospholipid Syndrome Imperial College London
Not applicableStudy completedNCT04963881What this trial is testingAntiphospholipid Antibodies in Patients of Antiphospholipid Syndrome (APS) With Systemic Lupus Erythematosus (SLE).Who this might be right forAnti-phospholipid Antibobodies in Patients of SLE Presenting With Thrombosis or Pregnancy Complications Fatima Memorial Hospital 60
Not applicableLooking for participantsNCT07372170What this trial is testingObservational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS PatientsWho this might be right forAntiphospholipid Syndrome (APS)Venous Thrombosis (Disorder)Thrombophilia Infanta Leonor University Hospital 600
Not applicableStudy completedNCT02782039What this trial is testingRegister of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)Who this might be right forAnti-Phospholipids Syndrome (APS)Systemic Lupus Erythematosus (SLE) Assistance Publique - Hôpitaux de Paris 868
Testing effectiveness (Phase 2)WithdrawnNCT07172022What this trial is testingEvaluate Crovalimab in People With Antiphospholipid Syndrome (APS)Who this might be right forAntiphospholipid Syndrome Hoffmann-La Roche
Not applicableUnknownNCT01956188What this trial is testingOmega 3 in LES and APSWho this might be right forSystemic Lupus ErythematosusPrimary Antiphospholipid Syndrome University of Sao Paulo 22
Not applicableLooking for participantsNCT05904301What this trial is testingArmenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory DiseasesWho this might be right forBehcet DiseaseAntineutrophil Cytoplasmic Antibody (ANCA) Positive VasculitisTakayasu Arteritis+6 more Santé Arménie French-Armenian Research Center 800
Early research (Phase 1)Enrolling By InvitationNCT06723106What this trial is testingPhase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)Who this might be right forAntiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more Chugai Pharmaceutical 144
Not applicableNot Yet RecruitingNCT06929182What this trial is testingOBServaToIre interNational Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux DirectsWho this might be right forAntiphospholipid Syndrome (APS)Direct Oral Anticoagulants (DOACs)Thrombotic and Bleeding Events+1 more Central Hospital, Nancy, France 500
Testing effectiveness (Phase 2)WithdrawnNCT04275778What this trial is testingHYDROxychloroquine in Syndrome Primary AntiPhospholipidWho this might be right forAntiphospholipid Syndrome in PregnancyAnticoagulants Assistance Publique - Hôpitaux de Paris
Not applicableLooking for participantsNCT00616317What this trial is testingRegister for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally StudyWho this might be right forAntiphospholipid Syndrome University of California, Davis 50
Early research (Phase 1)Active Not RecruitingNCT07632976What this trial is testingA Phase I, Dose Escalation, Open-label, Multicenter Study of EA5 Injection in Adults With APS and Recurrent ThrombosisWho this might be right forAntiphospholipid Syndrome (APS)Thrombosis Shanghai Lanyi Therapeutics Co., Ltd. 12